prof. dr. E. (Eelko) Hak

Full professor of Clinical Pharmacoepidemiology/Educational director Pharmacy-MPS

prof. dr. E. (Eelko) Hak
Telephone:
+31 50 36 38707 (Direct)
+31 50 36 37576 (Secretariat)
E-mail:
e.hak rug.nl

Research

Postal address:
A Deusinglaan1
Gebouw 3214, ruimte 0457
9713 AV
Groningen
Netherlands
Phone: +31 50 363 8707
  1. 2012
  2. Liu, W. M., Nahar, T. E. R., Jacobi, R. H. J., Gijzen, K., van Beek, J., Hak, E., Jonges, M., Boog, C. J. P., van der Zeijst, B. A. M., & Soethout, E. C. (2012). Impaired production of INF-alpha by dendritic cells of older adults leads to a lower CD8+T cell response against influenza. Vaccine, 30(9), 1659-1666. https://doi.org/10.1016/j.vaccine.2011.12.105
  3. Munster, J. M., Leenders, A. C. A. P., Hamilton, C. J. C. M., Hak, E., Aarnoudse, J. G., & Timmer, A. (2012). Placental histopathology after Coxiella burnetii infection during pregnancy. Placenta, 33(2), 128-131. https://doi.org/10.1016/j.placenta.2011.11.012
  4. 2011
  5. Dijkstra, F., Riphagen-Dalhuisen, J., Wijers, N., Hak, E., van der Sande, M. A. B., Morroy, G., Schneeberger, P. M., Schimmer, B., Notermans, D. W., & van der Hoek, W. (2011). Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization. Epidemiology And Infection, 139(9), 1332-1341. https://doi.org/10.1017/S0950268810002621
  6. van Gils, E. J. M., Hak, E., Veenhoven, R. H., Rodenburg, G. D., Bogaert, D., Bruin, J. P., & van Alphen, L. (2011). Effect of seven-valent pneumococcal conjugate vaccine on staphylococcus aureus colonisation in a randomised controlled trial. PLoS ONE, 6(6), [20229]. https://doi.org/10.1371/journal.pone.0020229
  7. Looijmans-van den Akker, I., Hulscher, M. E., Verheij, T. J. M., Riphagen-Dalhuisen, J., van Delden, J. J. M., & Hak, E. (2011). How to develop a program to increase influenza vaccine uptake among workers in health care settings? Implementation Science, 6, [47]. https://doi.org/10.1186/1748-5908-6-47
  8. Spijkerman, J., van Gils, E. J. M., Veenhoven, R. H., Hak, E., Yzerman, E. P. F., van der Ende, A., Wijmenga-Monsuur, A. J., van den Dobbelsteen, G. P. J. M., & Sanders, E. A. M. (2011). Carriage of streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerging Infectious Diseases, 17(4), 584-591. https://doi.org/10.3201/eid1704101115
  9. Hopman, C. E., Riphagen-Dalhuisen, J., Looijmans-van den Akker, I., Frijstein, G., Van der Geest-Blankert, A. D., Danhof-Pont, M. B., De Jager, H. J., Bos, A. A., Smeets, E., De Vries, M. J., Gallee, P. M., Lenderink, A. F., & Hak, E. (2011). Determination of factors required to increase uptake of influenza vaccination among hospital-based healthcare workers. Journal of Hospital Infection, 77(4), 327-331. https://doi.org/10.1016/j.jhin.2010.10.009
  10. Venmans, L. M. A. J., Gorter, K. J., Hak, E., Grypdonck, M. H. F., de Bruijn, O., & Rutten, G. E. H. M. (2011). Management of infections in type 2 diabetes from the patient's perspective: A qualitative approach. Primary Care Diabetes, 5(1), 33-37. https://doi.org/10.1016/j.pcd.2010.09.003
  11. Gefenaite, G., Smit, M., Nijman, HW., Tami, A., Drijfhout, I. H., Pascal, A., Postma, M., Wolters, B. A., van Delden, JJM., Wilschut, J., & Hak, E. (2011). Waarom ging de eerste ronde HPV-vaccinatieprogramma mis? Inzicht vanuit gedragsonderzoek onder Nederlandse ouders. Infectieziekten Bulletin, 5, 167-169.
  12. 2010
  13. van Gils, E. J. M., Veenhoven, R. H., Hak, E., Rodenburg, G. D., Keijzers, W. C. M., Bogaert, D., Trzcinski, K., Bruin, J. P., van Alphen, L., van der Ende, A., & Sanders, E. A. M. (2010). Pneumococcal Conjugate Vaccination and Nasopharyngeal Acquisition of Pneumococcal Serotype 19A Strains. Journal of the American Medical Association, 304(10), 1099-1106.
  14. Looijmans-van den Akker, I., van Delden, J. J. M., Verheij, T. J. M., van der Sande, M. A. B., van Essen, G. A., Riphagen-Dalhuisen, J., Hulscher, M. E., & Hak, E. (2010). Effects of a multi-faceted program to increase influenza vaccine uptake among health care workers in nursing homes: A cluster randomised controlled trial. Vaccine, 28(31), 5086-5092. https://doi.org/10.1016/j.vaccine.2010.05.003
  15. Rodenburg, G. D., de Greeff, S. C., Jansen, A. G. C. S., de Melker, H. E., Schouls, L. M., Hak, E., Spanjaard, L., Sanders, E. A. M., & van der Ende, A. (2010). Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands. Emerging Infectious Diseases, 16(5), 816-823. https://doi.org/10.3201/eid1605.091223
  16. Rodenburg, G. D., van Gils, E. J. M., Veenhoven, R. H., Jones, N., Tcherniaeva, I., Hak, E., van Alphen, L., Berbers, G. A. M., & Sanders, E. A. M. (2010). Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses. Vaccine, 28(5), 1391-1396. https://doi.org/10.1016/j.vaccine.2009.10.151
  17. Munster, J. M., Leenders, A. C., Van der Hoek, W., Schneeberger, P. M., Rietveld, A., Riphagen-Dalhuisen, J., Stolk, R. P., Hamilton, C. J., de Vries, E., Meekelenkamp, J., Lo-Ten-Foe, J. R., Timmer, A., De Jong-Van den Berg, L. T., Aarnoudse, J. G., & Hak, E. (2010). Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial. BMC Womens Health, 10, [32]. https://doi.org/10.1186/1472-6874-10-32
  18. 2009
  19. Zijtregtop, E. A. M., Wilschut, J., Koelma, N., Van Delden, J. J. M., Stolk, R. P., Van Steenbergen, J., Broer, J., Wolters, B., Postma, M., & Hak, E. (2009). Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine? Vaccine, 28(1), 207-227. https://doi.org/10.1016/j.vaccine.2009.09.099
  20. Zuithoff, N. P. A., Vergouwe, Y., King, M., Nazareth, I., Hak, E., Moons, K. G. M., & Geerlings, M. I. (2009). A clinical prediction rule for detecting major depressive disorder in primary care: the PREDICT-NL study. Family practice, 26(4), 241-250. https://doi.org/10.1093/fampra/cmp036
  21. Looijmans-van den Akker, I., van Delden, J. J. M., Verheij, T. J. M., van Essen, G. A., van der Sande, M. A. B., Hulscher, M. E., & Hak, E. (2009). Which determinants should be targeted to increase influenza vaccination uptake among health care workers in nursing homes? Vaccine, 27(34), 4724-4730. https://doi.org/10.1016/j.vaccine.2009.05.013
  22. Jansen, A. G. S. C., Rodenburg, G. D., van der Ende, A., van Alphen, L., Veenhoven, R. H., Spanjaard, L., Sanders, E. A. M., & Hak, E. (2009). Invasive Pneumococcal Disease among Adults: Associations among Serotypes, Disease Characteristics, and Outcome. Clinical Infectious Diseases, 49(2), E23-E29. https://doi.org/10.1086/600045
  23. van Gils, E. J. M., Veenhoven, R. H., Hak, E., Rodenburg, G. D., Bogaert, D., IJzerman, E. P. F., Bruin, J. P., van Alphen, L., & Sanders, E. A. M. (2009). Effect of Reduced-Dose Schedules With 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Carriage in Children A Randomized Controlled Trial. Journal of the American Medical Association, 302(2), 159-167.

ID: 347541